<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Recent studies reveal success in treating spinal cord trauma with early, high-dose <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>As in spinal cord research, failure to find therapeutic effects with steroids in studies of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment may reflect institution of treatment too late and at too low dosage </plain></SENT>
<SENT sid="2" pm="."><plain>We presently test the efficacy of <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> administered early and at high doses using a cat temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We occluded the middle cerebral artery for 4 hours in 24 pentobarbital-anesthetized cats </plain></SENT>
<SENT sid="4" pm="."><plain>To enhance the probability of brain injury, we maintained the cats' serum <z:chebi fb="105" ids="17234">glucose</z:chebi> concentrations at high levels both during occlusion and for 6 hours afterward </plain></SENT>
<SENT sid="5" pm="."><plain>Using a blinded, randomized study design, we treated 12 cats with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (30 mg/kg IV infused over 15 minutes starting 30 minutes after occlusion followed by 5.4 mg.kg-1.h-1 IV for the next 23 hours) and 12 control cats with vehicle </plain></SENT>
<SENT sid="6" pm="."><plain>During and for 8 hours after occlusion, we monitored cerebral blood flow, brain and rectal temperatures, and multiple cardiovascular and blood compositional parameters </plain></SENT>
<SENT sid="7" pm="."><plain>We assessed brain pathological outcome after animal survival for 4 days or after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0011420'>death</z:hpo> from hemispheric <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Experimental and control animals showed similar early mortality rates (treated, 3/12; controls, 4/12) </plain></SENT>
<SENT sid="9" pm="."><plain>However, surviving <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>-treated cats (n = 9) showed a mean <z:mpath ids='MPATH_124'>infarct</z:mpath> size more than six times smaller than in the control animals (n = 8) (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>, 2.4 +/- 0.7% versus 15.6 +/- 6.2% of the ischemic territory, respectively; P &lt; .05) </plain></SENT>
<SENT sid="10" pm="."><plain>The <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi>-treated animals also showed less marked reduction in cerebral blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> than did the controls (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>, 58 +/- 5% versus 74 +/- 4%; P &lt; .005) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Administering <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> at high doses early after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> significantly reduces tissue injury in cats that survive 4 days of temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>This improvement in outcome occurs in the setting of significant increases in ischemic cerebral blood flow </plain></SENT>
<SENT sid="13" pm="."><plain>However, <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> treatment did not reduce hemispheric <z:hpo ids='HP_0000969'>edema</z:hpo> in animals that died early after temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
</text></document>